resveratrol has been researched along with Acute Lymphoid Leukemia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, TC; Delgado, M; Kacprzak, K; Urbaniak, A | 1 |
| Adan, A; Oğuz, O | 1 |
| Bączek, T; Grabowski, S; Koszałka, P; Miękus-Purwin, N; Niedźwiecki, M; Purwin, M; Stasiłojć, G | 1 |
| Kmiec, Z; Siedlecka-Kroplewska, K; Wozniak, M | 1 |
| Cierniak, A; Mazur, L; Opydo-Chanek, M; Rak, A | 1 |
| Azimi, A; Farshdousti Hagh, M; Nikasa, M; Vatanmakanian, M; Zadi Heydarabad, M | 1 |
| Asariha, M; Azimi, A; Bahar Aghdam, S; Karimi Yonjali, S; Mohammadi, H; Talebi, M; Zadi Heydarabad, M | 1 |
| Ghorbani, A; Jeddi-Tehrani, M; Keshavarz, SA; Koohdani, F; Shidfar, F; Zand, H | 1 |
| Azimi, A; Baradaran, B; Ghaderi, AH; Hagh, MF; Heydarabad, MZ; Hossein pour feizi, AA; Khanzedeh, T; Movassaghpour, AA; Shamsasenjan, K; Talebi, M; Yousefi, B | 1 |
| Denko, NC; Koong, AC; McNeil, B; Papandreou, I; Verras, M | 1 |
| Mao, P; Wang, S; Ying, Y; Zhou, R; Zhou, W | 1 |
| Ducore, JM; Keen, CL; Newman, JW; Pedersen, TL; Storms, DH; Zunino, SJ | 2 |
| Platanias, LC; Vakana, E | 1 |
| Storms, DH; Zunino, SJ | 1 |
| Dörrie, J; Gerauer, H; Wachter, Y; Zunino, SJ | 1 |
1 review(s) available for resveratrol and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.
Topics: AMP-Activated Protein Kinase Kinases; Genes, abl; Hematologic Neoplasms; Humans; Leukemia; Metformin; Phosphatidylinositol 3-Kinase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases | 2011 |
15 other study(ies) available for resveratrol and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Activity of resveratrol triesters against primary acute lymphoblastic leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esters; G1 Phase Cell Cycle Checkpoints; Humans; Molecular Structure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes; Structure-Activity Relationship | 2017 |
Involvement of Sphingolipid Metabolism Enzymes in Resveratrol-Mediated Cytotoxicity in Philadelphia-Positive Acute Lymphoblastic Leukemia.
Topics: Apoptosis; Cell Line, Tumor; Humans; Poly(ADP-ribose) Polymerase Inhibitors; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Sphingolipids | 2022 |
The Cooperative Anti-Neoplastic Activity of Polyphenolic Phytochemicals on Human T-Cell Acute Lymphoblastic Leukemia Cell Line MOLT-4 In Vitro.
Topics: Apoptosis; Cell Line; Cell Line, Tumor; Curcumin; Genistein; Humans; Phytochemicals; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quercetin; Resveratrol | 2022 |
The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Resveratrol; Wine | 2019 |
Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells.
Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; DNA Damage; Drug Synergism; Humans; Membrane Potential, Mitochondrial; Nitrophenols; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Sulfonamides; Tumor Suppressor Protein p53 | 2017 |
Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Resveratrol | 2018 |
Regulatory Effect of Resveratrol and Prednisolone on MDR1\
Protein Expression in Acute Lymphoblastic Leukemia Cell\
Line (CCRF-CEM)
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Resveratrol; Tumor Cells, Cultured | 2019 |
PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress.
Topics: DNA Damage; Humans; MAP Kinase Signaling System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Stilbenes | 2015 |
Time--and Concentration--Dependent Effects of Resveratrol on miR 15a and miR16-1 Expression and Apoptosis in the CCRF-CEM Acute Lymphoblastic Leukemia Cell Line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression; Humans; MicroRNAs; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes; Time Factors; Up-Regulation | 2015 |
Plant stilbenes induce endoplasmic reticulum stress and their anti-cancer activity can be enhanced by inhibitors of autophagy.
Topics: Antimalarials; Antineoplastic Agents; Antioxidants; Autophagy; Blotting, Western; Cell Proliferation; Chloroquine; Drug Synergism; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fibrosarcoma; High-Throughput Screening Assays; Humans; Plants; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Small Molecule Libraries; Stilbenes; Tumor Cells, Cultured | 2015 |
miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.
Topics: 3' Untranslated Regions; Antineoplastic Agents, Phytogenic; Case-Control Studies; Cell Line, Tumor; Gene Expression Regulation, Leukemic; Humans; Insulin-Like Growth Factor Binding Protein 3; MicroRNAs; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; RNA, Small Interfering; Stilbenes | 2017 |
Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Female; Humans; Infusions, Parenteral; Mice; Mice, Inbred NOD; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes | 2012 |
Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Line, Tumor; Diet; Female; Glucuronides; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes; Sulfates; Tumor Burden; Vincristine; Xenograft Model Antitumor Assays | 2012 |
Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Isoquinolines; Jurkat Cells; Membrane Potentials; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes | 2006 |
Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 9; Caspases; Enzyme Activation; Fas Ligand Protein; fas Receptor; Humans; Intracellular Membranes; Leukocytes, Mononuclear; Membrane Glycoproteins; Membrane Potentials; Mitochondria; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes; Translocation, Genetic; Tumor Cells, Cultured | 2001 |